EP4056176
Aðferð til að draga úr hættu á hjarta- og æða-atburðum í einstaklingi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.4.2019EP published:
24.4.2024EP application number:
22171033.8
EP translation filed:
15.7.2024Grant published:
15.9.2024EPO information:
European Patent Register
Max expiry date:
21.4.2039Expiry date:
21.4.2026Next due date:
30.4.2026
Title in English:
METHODS OF REDUCING THE RISK OF CARDIOVASCULAR EVENTS IN A SUBJECTLanguage of the patent:
English
Timeline
Today
22.4.2019EP application
24.4.2024EP Publication
15.7.2024Translation submitted
15.9.2024Registration published
21.4.2026Expires
Owner
Name:
Amarin Pharmaceuticals Ireland LimitedAddress:
88 Harcourt Street Dublin, D02 DK18 Dublin2, IE
Inventor
Name:
SONI, PareshAddress:
Mystic, 06355, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862735670 PDate:
24.9.2018Country:
US
Number:
201862735680 PDate:
24.9.2018Country:
US
Number:
201862758387 PDate:
9.11.2018Country:
US
Number:
201962813888 PDate:
5.3.2019Country:
US
Number:
201962818514 PDate:
14.3.2019Country:
US
Classification
Categories:
A61K 31/232, A61K 31/366, A61K 31/40, A61K 31/505, A61K 45/06, A61K 47/06, A61P 9/10, A61P 9/00, A61K 31/202
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 18.3.2025
Expires: 21.4.2026
Payer: Árnason Faktor ehf.